United States · FDA National Drug Code directory
GAVILAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0312_3a86670e-4e74-3a85-e063-6394a90ad435
- Product NDC
- 17856-0312
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210126
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 17 g in 1 BAG (17856-0312-1) · 17856-0312-1
- 8.5 g in 1 BAG (17856-0312-2) · 17856-0312-2
- 17 g in 1 CUP (17856-0312-3) · 17856-0312-3
- 4 g in 1 BAG (17856-0312-4) · 17856-0312-4
- 50 CUP in 1 CASE (17856-0312-5) / 8.5 g in 1 CUP · 17856-0312-5
- 72 POUCH in 1 CASE (17856-0312-6) / 4.5 g in 1 POUCH · 17856-0312-6
- 50 BAG in 1 BOX, UNIT-DOSE (17856-0312-7) / 4.25 g in 1 BAG · 17856-0312-7
- 72 BAG in 1 BOX, UNIT-DOSE (17856-0312-8) / 4.25 g in 1 BAG · 17856-0312-8
- 50 CUP in 1 BOX, UNIT-DOSE (17856-0312-9) / 4.25 g in 1 CUP · 17856-0312-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →